Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any fetal akinesia deformation sequence in which the cause of the disease is a mutation in the NUP88 gene.
Features include always present findings: Wide nasal bridge, Joint stiffness present at birth (arthrogryposis multiplex congenita), Decreased fetal movement, and High palate and others; and common findings: Skeletal muscle atrophy, Polyhydramnios, Broad neck, and Short neck and others. 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Pregnancy and birth | 3 | Fetal pleural effusion, Absence of stomach bubble on fetal sonography, Decreased fetal movement |
NUP88 encodes nucleoporin 88 (741 aa). Component of nuclear pore complex Highest expression in Testis (81.2 TPM) and Cells EBV-transformed lymphocytes (61.5 TPM).
Fetal akinesia deformation sequence 4 is associated with mutations in the NUP88 gene on chromosome 17.
NUP88 is classified as a druggable target with score 0.0.
Genetic testing for NUP88 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for fetal akinesia deformation sequence 4 has been reported in the published literature.
Phenotype severity distribution: 9 always present features, 6 common features.
No clinical trials have been registered for fetal akinesia deformation sequence 4.
5 publications have been identified in PubMed for fetal akinesia deformation sequence 4. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (40%), and Diagnostic / Biomarker (20%).
Arduç A (2026). [PMID: 40195522](https://pubmed.ncbi.nlm.nih.gov/40195522/). *Eur J Hum Genet*. [Diagnostic / Biomarker]
McAdam A (2025). [PMID: 39713852](https://pubmed.ncbi.nlm.nih.gov/39713852/). *Am J Med Genet A*. [Case Report / Case Series]
Begum J (2025). [PMID: 39681016](https://pubmed.ncbi.nlm.nih.gov/39681016/). *Eur J Obstet Gynecol Reprod Biol*. [Case Report / Case Series]
Li Y (2024). [PMID: 39080077](https://pubmed.ncbi.nlm.nih.gov/39080077/). *J Cancer Res Clin Oncol*. [Review / Meta-Analysis]
Fare CM (2024). [PMID: 38383349](https://pubmed.ncbi.nlm.nih.gov/38383349/). *Nucleus*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:58 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints | 2 | Skeletal muscle atrophy, Excessive outward curvature of the upper spine (kyphosis) |
Muscles | 2 | Skeletal muscle atrophy, Joint stiffness present at birth (arthrogryposis multiplex congenita) |
Lungs and breathing | 1 | Fetal pleural effusion |
Arms and legs | 1 | Rocker bottom foot |
Head and neck | 1 | High palate |